Review
doi: 10.1136/jcp.2004.019588.
ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis
Affiliations
- PMID: 15677531
- PMCID: PMC1770577
- DOI: 10.1136/jcp.2004.019588
Item in Clipboard
Review
ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis
J Clin Pathol.
2005 Feb.
Abstract
Renal stones have afflicted humans for millennia but there is still no solution to this problem. This review discusses the laboratory and metabolic aspects of the clinical management of patients with renal stones, both primary and secondary in origin. First, non-pharmacological interventions such as increased fluid intake, decreased protein consumption, dietary changes in sodium, calcium, oxalate, potassium, purine, vitamins, and essential fatty acids are considered. Then specific pharmacological treatment to modify urine calcium, oxalate, urate, citrate, and acidity are considered. Finally, more unusual types of stone are examined.
Similar articles
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Predictive value of kidney stone composition in the detection of metabolic abnormalities.Am J Med. 2003 Jul;115(1):26-32. doi: 10.1016/s0002-9343(03)00201-8. Am J Med. 2003. PMID: 12867231
-
Medical therapy, calcium oxalate urolithiasis.Urol Clin North Am. 1997 Feb;24(1):117-33. doi: 10.1016/s0094-0143(05)70358-x. Urol Clin North Am. 1997. PMID: 9048856 Review.
-
Treatment of renal calculi.Adv Intern Med. 1980;26:373-92. Adv Intern Med. 1980. PMID: 7013442 Review. No abstract available.
-
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.J Endourol. 2017 Dec;31(12):1335-1341. doi: 10.1089/end.2017.0352. J Endourol. 2017. PMID: 29084490
Cited by
-
Effect of the location and severity of partial ureteral obstruction on urinary system stone disease formation.Sci Rep. 2025 Apr 4;15(1):11560. doi: 10.1038/s41598-025-96879-7. Sci Rep. 2025. PMID: 40185910 Free PMC article.
-
Pathological Mineralization: The Potential of Mineralomics.Materials (Basel). 2019 Sep 25;12(19):3126. doi: 10.3390/ma12193126. Materials (Basel). 2019. PMID: 31557841 Free PMC article. Review.
-
Concentration effect of trace metals in Jordanian patients of urinary calculi.Environ Geochem Health. 2008 Feb;30(1):11-20. doi: 10.1007/s10653-007-9103-3. Epub 2007 May 3. Environ Geochem Health. 2008. PMID: 17476575
-
Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.Biomed Res Int. 2013;2013:292953. doi: 10.1155/2013/292953. Epub 2013 Sep 14. Biomed Res Int. 2013. PMID: 24151593 Free PMC article. Review.
-
Nomogram to predict the risk of adverse outcomes in patients with residual stones following percutaneous nephrolithotomy.Int Braz J Urol. 2023 Sep-Oct;49(5):599-607. doi: 10.1590/S1677-5538.IBJU.2023.0111. Int Braz J Urol. 2023. PMID: 37390125 Free PMC article.
References
-
- Bihl G, Meyers A. Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet 2001;358:651–6. - PubMed
-
- Wilkinson H . Clinical investigation and management of patients with renal stones. Ann Clin Biochem 2001;38:180–7. - PubMed
-
- Pantonowitz D, Pollen J, Politzer WM. Urinary calculi. S Afr Med J 1973;43:128–31. - PubMed
-
- Meyers AM, Whalley N, Martins M. Diagnostic and therapeutic aspects of recurrent renal stones disease. African Journal of Neprology 1998;2:12–17.
-
- Daudon M, Donsimoni R, Hennequin C, et al. Sex- and age-related composition of 10617 calculi analysed by infrared spectroscopy. Urol Res 1995;23:319–26. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
